Vivanza Biosciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vivanza Biosciences Ltd. on BSE

Load latest

Vivanza Biosciences Ltd.

22 Mar 2025

2.12

3.41%

SAST

Vivanza Biosciences Ltd - 530057 - Closure of Trading Window

BSE India

The trading window for dealing in the equity shares of the Company shall remain closed for all designated persons and their immediate relatives, from 1st April, 2025 till 48 hours after the declaration of Audited Financial results of the Company for the quarter and year ended 31st March, 2025.

pdf

Vivanza Biosciences Ltd.

20 Mar 2025

2.12

3.41%

Company Update

Vivanza Biosciences Ltd - 530057 - Appointment of Company Secretary and Compliance Officer

BSE India

APPOINTMENT OF MS. SIDDHI SHAH AS A COMPANY SECRETARY & COMPLIANCE OFFICER W.E.F 20TH MARCH, 2025.

pdf

Vivanza Biosciences Ltd.

20 Mar 2025

2.12

3.41%

Corp. Note

Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Appointment Of Company Secretary

BSE India

Appointment of Ms. Siddhi Shah as Company Secretary w.e.f. 20.03.2025

pdf

Vivanza Biosciences Ltd.

11 Mar 2025

2.12

3.41%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Disclosure under Regulation 30 of SEBI (LODR) regarding intimation of Mr. Aagam Shah (DIN: 10602386), Independent Director of the Company.

pdf

Vivanza Biosciences Ltd.

12 Feb 2025

2.12

3.41%

Corp. Note

Vivanza Biosciences Ltd - 530057 - Integrated Filing (Financial)

BSE India

INTEGRATED FILING- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2024.

pdf

Vivanza Biosciences Ltd.

01 Feb 2025

2.12

3.41%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015-Publication of Financial Results for the Quarter & Nine months ended 31st December, 2024

pdf

Vivanza Biosciences Ltd.

31 Jan 2025

2.12

3.41%

Company Update

Vivanza Biosciences Ltd - 530057 - Outcome Of The Board Meeting.

BSE India

Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. to consider and approve the Un-audited Financial Results for the Quarter and Nine months ended 31st December, 2024.

pdf

Vivanza Biosciences Ltd.

31 Jan 2025

2.12

3.41%

Result

Vivanza Biosciences Ltd - 530057 - Results For Quarter And Nine Months Ended 31St December, 2024

BSE India

Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024.

pdf

Vivanza Biosciences Ltd.

30 Jan 2025

2.12

3.41%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015.

pdf

Vivanza Biosciences Ltd.

24 Jan 2025

2.12

3.41%

Board Meeting

Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Intimation Under Regulation 29(1)(A) And Regulation …

BSE India

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December, 2024; 2. Any other business with the permission of Chairman.

pdf

Is Vivanza Biosciences Ltd. worth buying?

25 Votes:

Buy 60.0%

Sell 16.0%

Hold 24.0%

51.38% Fall from 52W High

High volume today

Vivanza Biosciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vivanza Biosciences Ltd. on BSE